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Parkinson's disease is a pervasive, ageing-related neurodegenerative disease the cardinal motor symptoms of which reflect the loss of a small group of neurons, the dopaminergic neurons in the substantia nigra pars compacta 1 (SNc) . Mitochondrial oxidant stress is widely viewed as being responsible for this loss 2 , but why these particular neurons should be stressed is a mystery. Here we show, using transgenic mice that expressed a redox-sensitive variant of green fluorescent protein targeted to the mitochondrial matrix, that the engagement of plasma membrane L-type calcium channels during normal autonomous pacemaking created an oxidant stress that was specific to vulnerable SNc dopaminergic neurons. The oxidant stress engaged defences that induced transient, mild mitochondrial depolarization or uncoupling. The mild uncoupling was not affected by deletion of cyclophilin D, which is a component of the permeability transition pore, but was attenuated by genipin and purine nucleotides, which are antagonists of cloned uncoupling proteins. Knocking out DJ-1 (also known as PARK7 in humans and Park7 in mice), which is a gene associated with an early-onset form of Parkinson's disease, downregulated the expression of two uncoupling proteins (UCP4 (SLC25A27) and UCP5 (SLC25A14)), compromised calciuminduced uncoupling and increased oxidation of matrix proteins specifically in SNc dopaminergic neurons. Because drugs approved for human use can antagonize calcium entry through L-type channels, these results point to a novel neuroprotective strategy for both idiopathic and familial forms of Parkinson's disease.
Calcium entry through L-type channels in SNc dopaminergic neurons occurs throughout the pacemaking cycle 3, 4 , contrasting them with neighbouring dopaminergic neurons in the ventral tegmental area (VTA), which are much less affected in Parkinson's disease 5 (Fig. 1a, b ). Although prominent, this influx is not necessary for pacemaking, because treatment with the dihydropyridine L-type channel antagonist isradipine eliminates cytosolic calcium oscillations but leaves pacemaking intact 6 (Fig. 1a) .
Calcium entry during pacemaking comes at a metabolic cost, as it must be extruded by ATP-dependent processes. This demand is met primarily by mitochondria through oxidative phosphorylation. Superoxide and reactive oxygen species are by-products of oxidative phosphorylation, raising the possibility that calcium entry creates mitochondrial oxidant stress. To determine whether this was the case, we generated 7 transgenic mice expressing a redox-sensitive variant of green fluorescent protein (roGFP) with a mitochondrial-matrixtargeting sequence (mito-roGFP). To limit expression to monoaminergic neurons, we expressed mito-roGFP under the control of the tyrosine hydroxylase promoter (TH-mito-roGFP; Fig. 1c ). Dopaminergic neurons in the SNc and the adjacent VTA from these mice robustly expressed mito-roGFP that co-localized with mitochondrial markers (Fig. 1c-e and Supplementary Fig. 1 ), providing a reversible, quantitative means of monitoring the oxidation of mitochondrial matrix proteins. Because the expression of mito-roGFP was restricted to a small set of neurons, it was possible to monitor the mitochondrial redox state in individual neurons deep in brain slices from young adult mice using two-photon laser scanning microscopy (2PLSM).
In VTA dopaminergic neurons, the basal oxidation of mito-roGFP was very low (Fig. 1f ). In contrast, the oxidation of mito-roGFP was significantly higher in neighbouring SNc dopaminergic neurons ( Fig. 1g, h) . In juvenile SNc dopaminergic neurons, where pacemaking is similar to that of VTA neurons, mitochondrial oxidant stress also was low ( Fig. 1h ). To verify that this stress was not an artefact of brain slicing, we generated a transgenic mouse that expressed mito-roGFP under the control of the cytomegalovirus promoter, yielding robust neuronal expression in the cerebral cortex, striatum and hippocampus. In brain slices from these mice, principal neurons in each of these regions were devoid of any significant mitochondrial oxidation (Supplementary Fig. 2 ), demonstrating that slicing per se did not create oxidant stress.
What did contribute significantly to the mitochondrial oxidant stress was calcium influx through plasma membrane L-type channels. Antagonizing L-type channels drastically lowered the extent of mito-roGFP oxidation (Fig. 1g, h) , as did slowing pacemaking by cooling ( Fig. 1i ). L-type channel antagonists had no effect on the oxidation of matrix proteins in neighbouring VTA dopaminergic neurons ( Fig. 1h ). Blocking calcium entry into mitochondria from the cytoplasm with Ru360 8 diminished roGFP oxidation (without affecting pacemaking) ( Fig. 1h ), suggesting that it helped to drive oxidative phosphorylation 9 .
Loss-of-function mutations in DJ-1 are linked to an autosomal recessive, early-onset form of Parkinson's disease 10 . Although DJ-1 is not an antioxidant enzyme itself, it is redox sensitive and participates in signalling cascades made active by mitochondrial superoxide generation. To examine its role in SNc dopaminergic neurons, DJ-1 knockout mice were crossed with the TH-mito-roGFP mice. SNc dopaminergic neurons from these mice had normal pacemaking and oscillations in intracellular calcium concentration ( Fig. 2a ). However, basal mito-roGFP oxidation was nearly complete at physiological temperatures in these neurons, so we re-examined cells at a lower temperature. These studies confirmed the robust difference in oxidation between wild-type and DJ-1 knockout neurons seen at higher temperatures (Fig. 2b, c) . This difference was virtually abolished by antagonism of L-type calcium channels (Fig. 2b, c) . In contrast, the mitochondria in neighbouring VTA dopaminergic neurons were unaffected by DJ-1 deletion ( Fig. 2d) .
A clue about the role of DJ-1 in attenuating mitochondrial oxidant stress came from measurements of the inner mitochondrial membrane (IMM) potential with the cationic dye tetramethylrhodamine methylester (TMRM) ( Fig. 3a and Supplementary Movie 1). In VTA dopaminergic neurons, TMRM fluorescence was robust and stable for long periods (Fig. 3b ). In contrast, mitochondrial TMRM fluorescence in neighbouring SNc dopaminergic neurons repeatedly fell and then rose back to peak values, indicating that mitochondria were transiently depolarizing ( Fig. 3b and Supplementary Movie 1). This 'flickering' was stable for long periods (.60 min) and was peculiar to SNc dopaminergic neurons, suggesting that it was not a product of the preparation ( Supplementary Fig. 2 ). Judging by a Nernst equation relating IMM potential to the ratio of mitochondrial to nuclear TMRM fluorescence 11 , it seemed that the flickering in mitochondrial potential was modest, corresponding to a IMM depolarization of only 20-30 mV.
Antagonizing plasma membrane L-type calcium channels with isradipine drastically reduced the rate of flickering ( Fig. 3c and Supplementary Movie 1), as did blocking calcium entry into the mitochondria with Ru360 ( Fig. 3c ). However, flickering was also attenuated by scavenging reactive oxygen species with the cell-permeable antioxidant N-(2-mercaptopropionyl)-glycine ( Fig. 3d ), suggesting that oxidant stress created by calcium entry, rather than calcium per se, was responsible for the mitochondrial flickering. This inference was consistent with the fact that mitochondrial flickering was roughly ten times slower than the oscillation in cytosolic calcium concentration (compare with Figs 1a and 3b).
Superoxide generation is known to trigger the opening of two types of ion channel that depolarize the IMM. One of these is the permeability transition pore 12 . However, TMRM flickering was normal in SNc dopaminergic neurons lacking cyclophilin D ( Fig. 3e ). Because cyclophilin D is one of its key modulators, this argues against a role for the permeability transition pore. Cyclosporin A, which is known to antagonize the permeability transition pore, decreased IMM flickering but also slowed or stopped pacemaking (and calcium influx), making it an unreliable diagnostic tool.
Uncoupling proteins (UCPs) are another class of mitochondrial ion channel whose open probability is increased by superoxide 13 . UCP To the right are shown a similar set of measurements after application of isradipine; we note the absence of a change in pacemaking rate but the loss of dendritic calcium transients (green trace) (P , 0.05, n 5 10 neurons). b, A similar set of measurements in a VTA dopaminergic neuron; these neurons consistently lacked dendritic calcium oscillations (n 5 6 neurons). c, Schematic of the TH-mito-roGFP construct. Below this is a singlecell reverse-transcription PCR (scRT-PCR) analysis of an mito-roGFPexpressing SNc dopaminergic neuron showing expression of tyrosine hydroxylase (TH) and Ca V 1.3 calcium channel mRNA but not calbindin (CBD) or Gad67 (Gad1) mRNA; similar results were obtained in all five neurons examined. bp, base pairs. MTS, matrix targeting sequence. and Aldrithiol (red trace). Relative oxidation is plotted as described in Methods. g, Mito-roGFP measurements from a SNc dopaminergic neuron (black trace) revealed a higher basal oxidation; treatment with isradipine reduced mitochondrial oxidation (green trace). h, Left: box plots summarizing mean redox measurements in control (n 5 9) and isradipine-treated (n 5 5) VTA dopaminergic neurons, and in control (n 5 14), isradipine-treated (n 5 9) and Ru360-treated (n 5 8) SNc dopaminergic neurons; SNc neurons were significantly more oxidized than VTA neurons (P , 0.05), and both isradipine and Ru360 significantly reduced oxidation in SNc neurons (P , 0.05). SNc dopaminergic neurons from young mito-roGFP mice (postnatal days (P) 10-12) were consistently less oxidized than adult neurons (P , 0.05, n 5 8). In these box plots (and those in Figs 2-4), the median is plotted as the central bar of the box, the upper and lower quartiles are the edges of the box, and the whiskers show the extremes of the distribution except for outliers, which are indicated using an asterisk. i, Box plots summarizing mean mito-roGFP measurements in SNc dopaminergic neurons in brain slices held at nearphysiological temperature (34-35 uC; n 5 14) and at room temperature (20-22 uC; n 5 5); there was significantly less oxidation at room temperature (P , 0.05). Statistical significance in all plots (with stated P values) is shown by an asterisk and was determined using a non-parametric test for comparing multiple groups (Kruskal-Wallis analysis of variance with Dunnet's post hoc test).
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opening modestly decreases the IMM potential 14 , making it a plausible mediator of the drop in IMM potential inferred from the TMRM measurements. Five UCPs have been cloned, three of which are robustly expressed in the SNc 15 (UCP2, UCP4 and UCP5). Application of the UCP antagonist genipin 16 significantly decreased the frequency and amplitude of mitochondrial flickering (Fig. 3e ), as did dialysing neurons with ATP ( Supplementary Fig. 3 ), providing support for UCP mediation 17 . The modest depolarization brought about by UCP activation is thought to diminish superoxide generation without significantly compromising ATP production, creating a protective, negative-feedback system to complement enzymatic defences against reactive oxygen species 17, 18 . If this were the case, blocking UCPs with genipin should cause superoxide concentrations and oxidation of mitochondrial proteins to increase. Indeed, genipin significantly elevated oxidation of mito-roGFP in SNc dopaminergic neurons, whereas it had no effect on mitochondrial oxidation in VTA dopaminergic neurons, where the UCP defence was not engaged (Fig. 4a ).
In DJ-1 null SNc dopaminergic neurons, mitochondrial flickering was reduced in amplitude and frequency, suggesting that their UCP defences were compromised ( Fig. 4b ). Because DJ-1 is largely found outside mitochondria, it is not likely to have a direct role in gating UCPs 19 . Another function of DJ-1 is to upregulate the expression of antioxidant proteins in response to stress 10, 20, 21 . Quantitative analysis of messenger RNA from the SNc of DJ-1 knockout mice revealed normal concentrations of Ucp2 mRNA ( Fig. 4c ), suggesting that UCP2 was not a participant in flickering-a conclusion consistent with examination of neurons from Ucp2 knockout mice (data not shown). In contrast, Ucp4 and Ucp5 mRNAs were downregulated in the SNc of DJ-1 knockout mice ( Fig. 4c ), bringing expression levels down to those found in the unstressed VTA. UCP expression levels in the cerebral cortex, striatum and hippocampus were largely unchanged by DJ-1 deletion ( Supplementary Fig. 4 ). The expression of mRNAs for the antioxidant enzymes manganese superoxide dismutase, glutathione peroxidase and catalase also were largely unchanged in the SNc of DJ-1 knockout mice, but immunoreactivity for manganese superoxide dismutase in situ was higher ( Supplementary Fig. 5 ). These data suggest that the elevation in mitochondrial oxidant stress in SNc dopaminergic neurons lacking DJ-1 was not due to lowered expression of antioxidant enzymes but rather to diminished UCP4 and UCP5 expression, blunting UCP-mediated mitochondrial uncoupling in response to calcium-induced stress.
Collectively, our studies demonstrate that in mature SNc dopaminergic neurons there is a basal mitochondrial oxidant stress. This oxidant stress is not a consequence of old age, pathology or the experimental preparation, but rather one of a neuronal design that engages L-type calcium channels during autonomous pacemaking. Mitochondrial oxidant stress of this sort has long been thought to be central to the aetiology of Parkinson's disease 2 . However, there has been no explanation for why this stress should be greater in a small population of mesencephalic neurons. Our results fill this gap (Fig. 4d ). The basal oxidant stress in SNc dopaminergic neurons was amplified by deletion of DJ-1, a gene associated with an early-onset, familial form of Parkinson's disease. In agreement with its putative role in regulating oxidant defences 10 , deletion of DJ-1 decreased the abundance of Ucp5 and Ucp4 mRNA in the SNc and compromised mitochondrial uncoupling in response to oxidant stress. Although the hypothesis that the effects of DJ-1 deletion on SNc dopaminergic neurons are mediated by reduced UCP expression remains to be definitively tested, this scenario provides an example of how a mutation in a widely expressed gene might manifest itself only in subpopulation of neurons. Our data also provide a potential explanation for the unusual accumulation of mitochondrial DNA mutations with age in SNc dopaminergic neurons 22, 23 . These mutations, which are attributable to accumulated superoxide exposure, diminish mitochondrial competence and promote phenotypic decline, proteostatic impairments and death 24, 25 .
Because the mitochondrial oxidant stress in SNc dopaminergic neurons was attenuated by exposure to dihydropyridines, our results also point to a potential neuroprotective strategy in both idiopathic and familial Parkinson's disease. Dihydropyridines have a long history of safe use in humans and have good pharmacokinetic properties, including the ability to cross the blood-brain barrier 26 . Recent epidemiological studies support their potential value, showing that dihydropyridine use substantially reduces the risk of Parkinson's disease 27, 28 .
METHODS SUMMARY
Midbrain slices were obtained from mice between postnatal days 21 and 30. Mice were handled according to guidelines established by the Northwestern University Animal Care and Use Committee, the National Institutes of Health and the Society for Neuroscience. We visualized midbrain slices using an infrared differential interference contrast video microscopy system (for patch-clamp recording) and imaged them using 2PLSM to measure calcium transients, the mitochondrial membrane potential (using TMRM dye) or the mito-roGFP signal. SNc or VTA neurons were filled with Alexa594 and Fluo-4 and calcium transients were imaged as described previously 6 . We calculated the mitochondrial membrane potential using a Nernst equation describing the distribution of TMRM 11 . Transgenic mice were generated by conventional approaches with a roGFP2 construct containing the tyrosine hydroxylase promoter and a mitochondrial-matrix-targeting sequence. Relative oxidation of mito-roGFP was determined from fluorescence measurements after fully reducing mitochondria with dithiothreitol and then fully oxidizing with Aldrithiol. Because the calibrated signal becomes independent of the absolute expression level of mito-roGFP, this strategy allows cell-to-cell comparisons. Results in the main body of the paper were derived from a single line of ; similar results were obtained in all five neurons examined. b, Mitochondrial mito-roGFP oxidation in DJ-1 knockout neurons was higher (red trace) than in control (wild-type, WT) SNc dopaminergic neurons (black trace); isradipine pre-treatment normalized oxidation of mito-roGFP (green trace). Experiments were done at 20-22 uC. c, Box plot summarizing mean mito-roGFP measurements in wild-type SNc neurons (n 5 5), DJ-1 knockout SNc neurons (n 5 6) and DJ-1 knockout neurons after isradipine pre-treatment (n 5 7); differences between wild-type and DJ-1 knockout neurons were significant (P , 0.05), as were differences between knockouts with and without isradipine treatment (P , 0.05). d, Box plot summarizing mean mito-roGFP measurements from wild-type VTA dopaminergic neurons (n 5 9), wild-type SNc dopaminergic neurons (n 5 14) and DJ-1 knockout VTA dopaminergic neurons (red box; n 5 4) at 34-35 uC. VTA dopaminergic neurons were unaffected by DJ-1 deletion (P . 0.05). Fig. 1 ) before (black trace) and after (red trace) application of genipin. Right: box plots summarizing mean mito-roGFP measurements following application of isradipine (green box; n 5 9) or genipin (red box; n 5 6) to SNc dopaminergic neurons; isradipine significantly decreased oxidation, whereas genipin increased oxidation (P , 0.05). Also show is a box plot of mito-roGFP measurements from VTA dopaminergic neurons following genipin application; genipin had no effect on these measurements (P . 0.05, n 5 5). b, Left: TMRM fluorescence measurement from a wild-type SNc dopaminergic neuron (black trace) and a DJ-1 knockout neuron (red trace). Right: box plots of mean frequency and amplitude data from wild-type (n 5 21) and DJ-1 knockout neurons (n 5 7); both amplitude and frequency of flickering were decreased in DJ-1 knockouts (P , 0.05). c, Quantitative PCR analysis of UCP expression in DJ-1 knockout mice: Ucp2 mRNA abundance (relative to GAPDH) was not significantly altered in VTA and SNc (P . 0.05, n 5 9). On the right, bar graphs plot the abundance of Ucp4 and Ucp5 mRNAs, normalized by that of Ucp2 in each sample. The relative abundance of Ucp4 and Ucp5 mRNA was decreased in the SNc of DJ-1 knockout mice (P , 0.05, n 5 9). Ucp4 mRNA abundance was higher in VTA from DJ-1 knockout mice (P , 0.05, n 5 9), whereas Ucp5 mRNA was unchanged. Error bars are s.e.m. d, Summary of the presented results linking calcium entry through L-type channels during pacemaking with elevated mitochondrial oxidant stress and opening of UCPs. The model also proposes that oxidized DJ-1 translocates to the nucleus and increases the transcription of Ucp4 and Ucp5 or the stability of the resulting mRNAs, leading to increased concentrations of UCP in the IMM. OXPHOS, oxidative phosphorylation; ROS, reactive oxygen species. 
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mice showing strong mito-roGFP expression. In the presence of a strong reducing agent as an estimate of roGFP concentration, we inferred that there was no significant difference between the expression levels of SNc and VTA neurons ( Supplementary Fig. 7) . The oxidation state of mitochondria was also verified in a second line of mice, one with lower mito-roGFP expression levels (Supplementary Fig. 7) , and in cultured cells expressing mito-roGFP ( Supplementary Fig. 6 ). The single-cell PCR approach that we used has been described previously 4 . Relative gene expression of UCPs was performed by reverse transcriptase reaction followed by quantitative PCR analysis. The immunostaining of manganese superoxide dismutase used standard approaches. Sample n represents number of mice. Our statistical analysis used non-parametric tests with a threshold for significance of less than 0.05.
METHODS
Tissue preparation. Acute midbrain coronal slices (220-mm thick) were obtained from male mice between postnatal ages 21 and 30 d, unless specified otherwise. The handling of mice and all procedures performed on them were approved by the Northwestern University Animal Care and Use Committee and were in accordance with the National Institutes of Health Guide to the Care and Use of Laboratory Animals and Society for Neuroscience guidelines. Mice were anaesthetized with a ketamine-xylazine mixture followed by transcardial perfusion with ice-cold, oxygenated artificial cerebrospinal fluid (ACSF) containing 125 mM NaCl, 2.5 mM KCl, 25 mM NaHCO 3 , 1.25mM NaH 2 PO 4 , 2mM CaCl 2 , 1mM MgCl 2 and 25 mM dextrose, pH 7.3, osmolality of 315-320 mOsM. After perfusion, mice were decapitated and brains were removed rapidly, followed by sectioning in ice-cold oxygenated ACSF using a vibratome (VT1000S Leica Microsystems). Midbrain slices were kept at 34 uC for 30 min before 2PLSM imaging experiments were performed. Dopaminergic neurons from the ventral tier of the SNc were identified during the imaging experiments on the basis of anatomical location in the slice and cell body size, and VTA neurons were identified by their anatomical location medial to the SNc. Generation of transgenic mice with mitochondrially targeted roGFP in dopaminergic neurons. Mitochondrial redox status was assessed with roGFP. Oxidation of two cysteine thiols located at the outer surface of the protein shifts the excitation spectrum of the protein, allowing ratiometric, real-time visualization of oxidation state 7 . roGFP plasmid was generated from the pEGFP-N1 plasmid (CLONTECH) by substituting surface-exposed residues on enhanced GFP with cysteines in appropriate positions as previously described, using a QuickChange site-directed mutagenesis kit (Stratagene). To target roGFP to the mitochondrial matrix, the matrix targeting sequence (MTS) from cytochrome oxidase subunit 4 was added at the amino terminus using the primer pair 59-AATGCCGCTAGCGCCACCATGCTGAGCCTGCGCCAGAGCATCCGCT TCTTCAAGCGCAGCGGCATCATGGTGAGCAAGGGCGAGGAGCTG-39 and 59-CCGCTCGAGTTACTTGTACAGCTCGTCCATGCC-39 while adding restriction sites for NheI and XhoI. The resulting PCR product was cloned into the pcDNA 3.1(1) vector (Invitrogen). MTS-roGFP was again amplified using primer pair 59-AATGCCGATATCGCCACCATGCTGAGC-39 and 59-CCGCTCGAGT TACTTGTACAGCTCGTCCATGCC-39, adding restriction sites for EcoRV and XhoI. PCR products were cloned in pCR4-TOPO vector (Invitrogen) and excised with EcoRI. To drive expression in dopaminergic neurons, this construct was ligated into the TH-SK3-PA plasmid containing the tyrosine hydroxylase (TH) promoter, a 9.0-kilobase (kb) genomic fragment, located 59 to the EcoRI restriction site. The TH-SK3-PA vector was kindly provided by Dr X. Zhuang at the University of Chicago, with permission from Dr J. H. Son 29 (Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York). Correct orientation of the gene was verified by sequencing. To allow in vivo expression of MTS-roGFP in dopaminergic neurons, a 10.5-kb SalI-HindIII fragment containing tyrosine hydroxylase promoter/MTS-roGFP/polyadenylation sequences was purified by electrophoresis with 0.8% agarose gel, and eluted with an Elutip column as per the manufacturer's instructions (Whatman Schleicher & Schuell). The purified DNA was used to generate transgenic mice by pronuclear microinjection at the Northwestern University Transgenic and Targeted Mutagenesis core. Several founder transgenic mice were identified by PCR using primers that hybridize with enhanced GFP. The founders for the roGFP mice were generated in a B6SJL genetic background and backcrossed to C57BL6 for our imaging experiments. Generation of transgenic mice carrying the CMV-promoter-driven, mitochondrially targeted roGFP gene. The oxidation and reduction status of the mitochondrial matrix was assessed by targeting the expression of a redox-sensitive protein (roGFP) to that compartment. A roGFP plasmid was generated from the pEGFP-N1 plasmid (CLONTECH) by site-directed mutagenesis using the Stratagene QuickChange kit. To target roGFP to mitochondria, MTS was added at the amino terminus using the primer pair 59-AATGCCGCTAGCGCCA CCATGCTGAGCCTGCGCCAGAGCATCCGCTTCTTCAAGCGCAGCGGCAT Catggtgagcaagggcgaggagctg-39 and 59-CCGCTCGAGTTACTTGTACAGCTC GTCCATGCC-39 while adding restriction sites for NheI and Xho I (underlined). The resultant plasmid was cloned into pcDNA 3.1(1) vector (Invitrogen). To drive mitochondrially targeted roGFP expression in different regions of the brain, a 2.05-kb MluI-DraIII fragment containing CMV promoter/MTS-roGFP/BGH polyadenylation sequences was purified and used in pronuclear injections at the Northwestern University Transgenic and Targeted Mutagenesis core. Several founder transgenic mice were identified by PCR using enhanced GFP primers. 2PLSM: calcium imaging. For dendritic measurements, SNc dopaminergic neurons in tissue slices (as described above) were loaded with Alexa Fluor 594 (50 mM) and Fluo-4 (200 mM) through the patch pipette. All experiments were performed at 34-35 uC. Images were acquired with a 360, NA-0.9 water-immersion lens. Dyes were allowed to equilibrate for at least 15 min before imaging. The twophoton excitation source was a Chameleon Ultra 2 tunable laser system (680-1,080 nm) using a Ti:sapphire gain medium with all-solid-state active components and a computer-optimized algorithm to ensure reproducible excitation wavelength, average power and peak power (Coherent Laser Group). Optical signals were acquired using an 810-nm excitation beam (80-MHz pulse repetition frequency and ,250-fs pulse duration) to excite Alexa and Fluo-4 dyes simultaneously. Laser power attenuation was achieved with two Pockels-cell electro-optic modulators (model 350-80, Con Optics). The two cells were aligned in series to provide enhanced modulation range for fine control of the excitation dose (0.1% steps over four decades). The laser-scanned images were acquired with a Bio-Rad Radiance MPD system. The fluorescence emission was collected with nondescanned photomultiplier tubes (PMTs). The green fluorescence (500-550 nm) was detected by a bialkali-cathode PMT and the red fluorescence (580-640 nm) was collected by a multi-alkali-cathode (S-20) PMT. The system digitizes the current from detected photons to 12 bits. The laser light transmitted through the sample was collected by the condenser lens and sent to another PMT to provide a bright-field transmission image in registration with the fluorescent images. Measurements were taken in a sample plane along dendritic segments (100-150 mm from the soma). Line scan signals were acquired (as described above) at 6 ms per line and 512 pixels per line with 0.18-mm pixels and 10-ms pixel dwell time. The time between the control and isradipine treatment measurements was 5-7 min. 2PLSM: TMRM mitochondrial imaging. Brain slices from wild-type or DJ-1 knockout mice (mixed background C57BL6x129SvEv) were incubated in 2-4 mM TMRM for 30 min at 34-35 uC; excess dye was then washed out with a TMRM-free ACSF solution. Imaging experiments were performed with TMRM-free ACSF solution at physiological temperatures (34-35 uC). Fluorescence (550-640 nm) was collected by a multi-alkali-cathode (S-20) PMT and a Dodt contrast-detector system that provided a bright-field transmission image (Prairie Technologies). The two-photon excitation source was a Chameleon Ultra 2 tunable laser system (706-1,000 nm) using a Ti:sapphire gain medium with all-solid-state active components and a computer-optimized algorithm to ensure reproducible excitation wavelength, average power and peak power (Coherent Laser Group). Signals were acquired using an 830-nm excitation beam (80-MHz pulse repetition frequency and ,250-fs pulse duration), in a fixed plane of focus with a pixel size between 0.18 and 0.21 mm. Fluorescence measurements in a region of interest (ROI) were monitored to ensure stationarity of the signal; samples with a drifting baseline (due to photobleaching of dye and/or washout) were discarded. Time-series scanning (1,000 frames) in a fixed plane was performed with a 4-ms dwell time at a rate of 2.5 frames per second. Drug applications ranged in duration from 30 to 60 min with similar control periods for comparison. Four to five ROIs in the cell body and one ROI in the nucleus were monitored in a typical experiment, and changes in TMRM fluorescence were plotted as a function of time.
The flickering frequency was determined by counting the number of transitions in 100-s epochs; fluorescence histograms were calculated with MATLAB (release 2009b). The change in mitochondrial membrane potential during flickering was estimated from the fluorescence in an ROI using a Nernst equation, V 5 (RT/ zF)ln(bF m /F n ), where R is the gas constant, T is temperature, F is Faraday's constant, z 5 1, F m is the fluorescence in the mitochondrial ROI, F n is the fluorescence of the nucleus in the same optical plane and b is a scaling factor. The scaling factor was calculated by assuming that the mitochondrial membrane potential was 2150 mV when the TMRM fluorescence was maximal. The existence of quenching was checked by application of the ATP synthase inhibitor oligomycin (10 mM); invariably, maximal fluorescence remained near that seen before application of oligomycin. For each flickering event, the percentage change in V was calculated by taking the difference in the estimates before and during the drop in fluorescence; the fluorescence during the drops was averaged.
These studies indicated that there was little or no quenching at the TMRM concentrations used; moreover, they excluded a role for ATP synthase in the origin of the flickering. These results also suggest that the TMRM concentration achieved in the mitochondria was not high enough to make fluorescence quenching an issue. Experiments illustrated in Supplementary Fig. 1 were performed using the internal solution described for 2PLSM calcium imaging, except that the internal solution contained 400 nM TMRM instead of Fluo-4. Fluorescence imaging was performed as above; the electrical activity of the cell was controlled in currentclamp mode as described in the figure legend. 2PLSM: mitochondrial roGFP imaging. Midbrain slices from wild-type, roGFP transgenic mice or DJ-1 knockout mice (crossed with roGFP transgenic mice) were incubated in ACSF at physiological temperatures (34-35 uC) followed by a recovery period at room temperature. Optical imaging of roGFP signals acquired using a LETTER RESEARCH In Fig. 2a of this Letter, the neuron reconstruction and the electrophysiology/calcium imaging traces were mismatched. In addition, in Fig. 2c , the wild-type SNc neurons should have been '(n 5 5)' rather than '(n 5 9)'. This was a typographical error, and the figure and error bars remain correct. These have all now been corrected in the online versions of the manuscript.
